rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches).

Autor: Watson CH; UK Health Security Agency, London, UK., Gsell PS; World Health Organization, Geneva, Switzerland., Hall Y; UK Health Security Agency, London, UK., Camacho A; Epicentre, Paris, France., Riveros X; World Health Organization, Geneva, Switzerland., Enwere G; World Health Organization, Geneva, Switzerland., Vicari A; World Health Organization, Geneva, Switzerland., Nadlaou SD; World Health Organization, Geneva, Switzerland., Toure A; World Health Organization, Geneva, Switzerland., Sani IM; World Health Organization, Geneva, Switzerland., Diallo A; World Health Organization, Geneva, Switzerland., Kolie C; World Health Organization, Geneva, Switzerland., Duraffour S; Bernhard-Nocht-Institut Für Tropenmedizin, Hamburg, Germany., Ifono K; Bernhard-Nocht-Institut Für Tropenmedizin, Hamburg, Germany., Maomou A; World Health Organization, Geneva, Switzerland., Dore K; World Health Organization, Geneva, Switzerland., Djidonou HA; World Health Organization, Geneva, Switzerland., Bagayoko A; World Health Organization, Geneva, Switzerland., Damey PP; World Health Organization, Geneva, Switzerland., Camara MN; World Health Organization, Geneva, Switzerland., Diallo FB; World Health Organization, Geneva, Switzerland., Oumar FT; World Health Organization, Geneva, Switzerland., Toure K; World Health Organization, Geneva, Switzerland., Diaby ML; World Health Organization, Geneva, Switzerland., Sylla L; World Health Organization, Geneva, Switzerland., Conde D; World Health Organization, Geneva, Switzerland., Kaba IL; World Health Organization, Geneva, Switzerland., Tipton T; University of Oxford, Oxford, UK., Eggo RM; London School of Hygiene and Tropical Medicine, London, UK., Marks M; London School of Hygiene and Tropical Medicine, London, UK., Roberts CH; London School of Hygiene and Tropical Medicine, London, UK., Strecker T; Philips University, Marburg, Germany., Günther S; Bernhard-Nocht-Institut Für Tropenmedizin, Hamburg, Germany., Keita S; Ministry of Health, Conakry, Guinea., Edmunds WJ; London School of Hygiene and Tropical Medicine, London, UK., Carroll MW; University of Oxford, Oxford, UK., Henao-Restrepo AM; World Health Organization, Geneva, Switzerland. henaorestrepoa@who.int.

Publikováno v: BMC medicine [BMC Med] 2024 Nov 07; Vol. 22 (1), pp. 523. Date of Electronic Publication: 2024 Nov 07.

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.

Autor: Gsell PS; World Health Organization, Geneva, Switzerland. Electronic address: gsellp@who.int., Camacho A; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK., Kucharski AJ; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK., Watson CH; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK., Bagayoko A; World Health Organization Ebola Vaccine Trial and Compassionate Use Team, Conakry, Guinea., Nadlaou SD; World Health Organization Ebola Vaccine Trial and Compassionate Use Team, Conakry, Guinea., Dean NE; Department of Biostatistics, University of Florida, Gainesville, FL, USA., Diallo A; World Health Organization Ebola Vaccine Trial and Compassionate Use Team, Conakry, Guinea., Diallo A; World Health Organization Ebola Vaccine Trial and Compassionate Use Team, Conakry, Guinea., Honora DA; World Health Organization Ebola Vaccine Trial and Compassionate Use Team, Conakry, Guinea., Doumbia M; Centre National d'Appui à la Lutte contre la Maladie, Bamako, Mali; World Health Organization Ebola Vaccine Trial and Compassionate Use Team, Conakry, Guinea., Enwere G; World Health Organization, Geneva, Switzerland., Higgs ES; Division of Clinical Research, National Institute of Allergy and Infectious Disease, Bethesda, MD, USA., Mauget T; World Health Organization Ebola Vaccine Trial and Compassionate Use Team, Conakry, Guinea., Mory D; World Health Organization Ebola Vaccine Trial and Compassionate Use Team, Conakry, Guinea., Riveros X; World Health Organization, Geneva, Switzerland., Oumar FT; World Health Organization Ebola Vaccine Trial and Compassionate Use Team, Conakry, Guinea., Fallah M; National Public Health Institute of Health, Monrovia, Liberia., Toure A; World Health Organization Ebola Vaccine Trial and Compassionate Use Team, Conakry, Guinea., Vicari AS; World Health Organization, Geneva, Switzerland., Longini IM; Department of Biostatistics, University of Florida, Gainesville, FL, USA., Edmunds WJ; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK., Henao-Restrepo AM; World Health Organization, Geneva, Switzerland., Kieny MP; World Health Organization, Geneva, Switzerland., Kéïta S; Ebola Response, Ministry of Health, Conakry, Guinea.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2017 Dec; Vol. 17 (12), pp. 1276-1284. Date of Electronic Publication: 2017 Oct 09.